Summary
The records show Eddie prescribing Schedule II stimulants, mostly by telehealth, to patients in four states where he has no license on record: New York, Rhode Island, Tennessee and Florida. Those prescriptions authorize refills, which federal law does not allow on Schedule II, and many are written above the labeled maximum daily dose. No DEA registration is on record for any of those patients’ states.
What the records show
Prescribing into states with no license on record
47 visits and 39 controlled prescriptions for patients in NY, RI, TN and FL. His licenses on record are AZ, KY, ME and SC.
Refills on Schedule II
39 of his 58 Schedule II prescriptions authorize 1 to 3 refills, 119 fills in all. Federal law does not allow refills on Schedule II. All 39 are the prescriptions written into the unlicensed states.
Dose above the labeled maximum
20 of the 39 are written above the labeled maximum daily dose.
No DEA registration for the patient’s state
None on record for any of the 39 prescriptions.
Which medications
Exhibit BAll five are Schedule II stimulants. Each bar splits into doses within and above the labeled maximum.
within labeled maximum above labeled maximum
Where he is licensed, and where he prescribed
Exhibit CLicensed on record
Practice location: Arizona. Licenses as listed in the records, not checked with the boards.
No license on record 5 patients, 43 of 47 visits by telehealth
Sample claims: lisdexamfetamine 70 mg
Exhibit D- 10 prescriptions to 4 patients (NY, RI, TN, FL), 9 of them by telehealth, all on Schedule II.
- Every prescription authorizes 1 to 3 refills, 32 fills in total.
- 5 of the 10 are above the labeled maximum of 70 mg a day: 140 mg a day for the NY patient, 210 mg for the TN patient.
| Date | State | Patient | Daily dose | Qty | Refills | Fills | Visit type | Paid | Claim |
|---|---|---|---|---|---|---|---|---|---|
| 2024-01-16 | RI | P-3e31bf | 70 mg | 30 | 2 | 3 | Video/phone | $139.06 | 38225306 |
| 2024-01-22 | TN | P-58085d | 210 mg ▲ | 90 | 1 | 2 | In person | $133.64 | 14237ee0 |
| 2024-02-03 | NY | P-5bf18b | 140 mg ▲ | 60 | 2 | 3 | Video/phone | $175.66 | d8993784 |
| 2024-03-01 | RI | P-3e31bf | 70 mg | 30 | 2 | 3 | Video/phone | $79.58 | 724a3f01 |
| 2024-06-05 | TN | P-58085d | 210 mg ▲ | 90 | 1 | 2 | Video/phone | $13.46 | 7cc5d7dc |
| 2024-07-07 | NY | P-5bf18b | 140 mg ▲ | 60 | 3 | 4 | Video/phone | $112.66 | 2903b517 |
| 2024-07-11 | RI | P-3e31bf | 70 mg | 30 | 3 | 4 | Video/phone | $99.74 | c2c564f6 |
| 2024-09-28 | NY | P-5bf18b | 140 mg ▲ | 60 | 2 | 3 | Video/phone | $83.91 | 867e3d73 |
| 2024-10-06 | RI | P-3e31bf | 70 mg | 30 | 3 | 4 | Video/phone | $69.62 | c98ba9b6 |
| 2024-10-15 | FL | P-851d74 | 70 mg | 30 | 3 | 4 | Video/phone | $92.44 | 1bab1152 |
| 32 | $999.77 | ||||||||
▲ above the labeled maximum of 70 mg a day. Patients are shown by reference code only. Claim shows the first 8 characters of the claim ID.
Estimated exposure for these claims
What it could grow into assumptions, not findings
| Triple damages3 × the paid amount, the usual False Claims Act measure. A legal theory, not a finding. | Legal theory | $2,999.31 |
| Civil penalties, ceiling10 claims × roughly $14,000 to $28,000 each. Adjusted every year; counsel must confirm. | Legal theory | $140,000 – $280,000 |
| Drug cost to payersAbout 50 thirty-capsule fills at an estimated $100 (generic) to $450 (brand) per fill. | Estimate | about $5,000 to $22,500 |
Evidence index
47 encounter and claim rows: service date, patient state, payer, paid amount, claim ID
See it in: Which states ›Medication request ID, drug, schedule, daily dose, labeled maximum, quantity, refills
See it in: Which medications ›State licenses on record, prescriber DEA schedules, DEA registration in the patient’s state
See it in: License and DEA ›10 prescriptions and their 10 visit claims
See it in: Sample claims ›Red flags for a criminal case
- 1
No DEA registration for the patient’s state
Exhibit CIn the records. None on record for any of the 39 Schedule II prescriptions, written for patients in NY, RI, TN and FL.
Why it matters. A practitioner needs DEA registration and state authority to prescribe controlled substances. Prescribing without them can be charged under the Controlled Substances Act on its own, whatever the medical merits (21 U.S.C. §§ 822 and 841(a)(1)).
- 2
Refills on Schedule II
Exhibit BIn the records. All 39 prescriptions authorize 1 to 3 refills, 119 fills in all.
Why it matters. Federal law bars refills on Schedule II (21 U.S.C. § 829(a)). It shows on the face of every prescription and needs no medical judgment to prove. Expect the defense that a system default added the refills.
- 3
Doses above the labeled maximum
Exhibit BIn the records. 20 of the 39. The NY patient was prescribed 140 mg a day and the TN patient 210 mg, against a labeled maximum of 70 mg.
Why it matters. The core test is whether a prescription was outside the usual course of professional practice or without a legitimate medical purpose (21 C.F.R. § 1306.04(a)). Doses far over the label are the evidence prosecutors use for that. Since Ruan v. United States (2022) they must also show he knew or intended it.
- 4
No license in the patient’s state
Exhibit AIn the records. 47 visits, 43 by telehealth, to patients in NY, RI, TN and FL, where no license is on record. Medicare and Medicare Advantage paid $4,003.13.
Why it matters. Practicing without a license is a state crime in many states. It also supports a health care fraud theory (18 U.S.C. § 1347) if the visits were billed as if lawful. The state boards must confirm his status.
- 5
The same pattern, repeated for months
Exhibit DIn the records. 10 lisdexamfetamine 70 mg prescriptions to 4 patients between January and October 2024. The NY patient got 140 mg three times and the TN patient 210 mg twice, with no change.
Why it matters. Repetition without correction is how prosecutors show knowledge instead of error, which Ruan requires. Pharmacy and prescription-monitoring records would show whether it continued.
Statute references are for orientation. Counsel confirms which charges fit, and the Department of Justice decides whether to bring them.
